Yang A, Sun H, Wang X
Cancer Drug Resist. 2024; 7:36.
PMID: 39403600
PMC: 11472569.
DOI: 10.20517/cdr.2024.84.
Wang F, Yu B, Yu Q, Wang G, Li B, Guo G
Front Pharmacol. 2023; 14:1295422.
PMID: 38149051
PMC: 10750250.
DOI: 10.3389/fphar.2023.1295422.
Brown J, Amend S, Austin R, Gatenby R, Hammarlund E, Pienta K
Mol Cancer Res. 2023; 21(11):1142-1147.
PMID: 37409952
PMC: 10618731.
DOI: 10.1158/1541-7786.MCR-23-0411.
Lassig M, Mustonen V, Nourmohammad A
Nat Rev Genet. 2023; 24(12):851-867.
PMID: 37400577
PMC: 11137064.
DOI: 10.1038/s41576-023-00623-8.
Pradeu T, Daignan-Fornier B, Ewald A, Germain P, Okasha S, Plutynski A
Biol Rev Camb Philos Soc. 2023; 98(5):1668-1686.
PMID: 37157910
PMC: 10869205.
DOI: 10.1111/brv.12971.
Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.
Tufail M, Cui J, Wu C
Am J Cancer Res. 2022; 12(7):2920-2949.
PMID: 35968356
PMC: 9360230.
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches.
Emran T, Shahriar A, Mahmud A, Rahman T, Abir M, Siddiquee M
Front Oncol. 2022; 12:891652.
PMID: 35814435
PMC: 9262248.
DOI: 10.3389/fonc.2022.891652.
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L
J Exp Clin Cancer Res. 2022; 41(1):15.
PMID: 34998404
PMC: 8742403.
DOI: 10.1186/s13046-021-02229-6.
What do cellular responses to acidity tell us about cancer?.
Blaszczak W, Swietach P
Cancer Metastasis Rev. 2021; 40(4):1159-1176.
PMID: 34850320
PMC: 8825410.
DOI: 10.1007/s10555-021-10005-3.
Causes and Consequences of Variable Tumor Cell Metabolism on Heritable Modifications and Tumor Evolution.
Ordway B, Swietach P, Gillies R, Damaghi M
Front Oncol. 2020; 10:373.
PMID: 32292719
PMC: 7119341.
DOI: 10.3389/fonc.2020.00373.
Dynamic Targeting in Cancer Treatment.
Wang Z, Deisboeck T
Front Physiol. 2019; 10:96.
PMID: 30890944
PMC: 6413712.
DOI: 10.3389/fphys.2019.00096.
What is pH regulation, and why do cancer cells need it?.
Swietach P
Cancer Metastasis Rev. 2019; 38(1-2):5-15.
PMID: 30707328
PMC: 6626545.
DOI: 10.1007/s10555-018-09778-x.
A Barter Economy in Tumors: Exchanging Metabolites through Gap Junctions.
Swietach P, Monterisi S
Cancers (Basel). 2019; 11(1).
PMID: 30669506
PMC: 6356692.
DOI: 10.3390/cancers11010117.
How is the evolution of tumour resistance at organ-scale impacted by the importance of the organ for fitness?.
Gidoin C, Ujvari B, Thomas F, Roche B
BMC Evol Biol. 2018; 18(1):185.
PMID: 30522441
PMC: 6282255.
DOI: 10.1186/s12862-018-1298-7.
Cooperation among cancer cells: applying game theory to cancer.
Archetti M, Pienta K
Nat Rev Cancer. 2018; 19(2):110-117.
PMID: 30470829
PMC: 8557269.
DOI: 10.1038/s41568-018-0083-7.
The Different Mechanisms of Cancer Drug Resistance: A Brief Review.
Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B
Adv Pharm Bull. 2017; 7(3):339-348.
PMID: 29071215
PMC: 5651054.
DOI: 10.15171/apb.2017.041.
Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis.
de Groot A, Roy S, Brown J, Pienta K, Amend S
Mol Cancer Res. 2017; 15(4):361-370.
PMID: 28209759
PMC: 5380470.
DOI: 10.1158/1541-7786.MCR-16-0436.
Solutions to Peto's paradox revealed by mathematical modelling and cross-species cancer gene analysis.
Caulin A, Graham T, Wang L, Maley C
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1673).
PMID: 26056366
PMC: 4581027.
DOI: 10.1098/rstb.2014.0222.
The multiple facets of Peto's paradox: a life-history model for the evolution of cancer suppression.
Brown J, Cunningham J, Gatenby R
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1673).
PMID: 26056365
PMC: 4581026.
DOI: 10.1098/rstb.2014.0221.
Intermittent hypoxia selects for genotypes and phenotypes that increase survival, invasion, and therapy resistance.
Verduzco D, Lloyd M, Xu L, Ibrahim-Hashim A, Balagurunathan Y, Gatenby R
PLoS One. 2015; 10(3):e0120958.
PMID: 25811878
PMC: 4374837.
DOI: 10.1371/journal.pone.0120958.
